Premium
In April, Swiss private investment firm Corinth Group made its debut investment in India with a bet on listed pharmaceutical company Morepen Group. While the Morepen investment was made from its global fund, the Corinth Group is currently in the process of launching an India focused alternative investment fund (AIF) ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
